BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Practical Radiation Oncology - Volume 4, Issue 5, September–October 2014, Pages e213-e216

Jonathan B. MD, Petra MD, Shalom MD, Jana L. MD,